Sub.:- Update on National Company Law Appellate Tribunal (NCLAT), New Delhi Order

We would like to inform you that appeal filed by Saravana Global Holdings Limited against the Order dated 1st February, 2019 passed by the Adjudicating Authority (National Company Law Tribunal), Single Bench, Chennai in MA/71/2019 in CP/682/IB/CB/2017 with National Company Law Appellate Tribunal (NCLAT), New Delhi has been dismissed.

Please find attached National Company Law Appellate Tribunal (NCLAT), New Delhi Order dismissing appeal filed by Saravana Global Holdings Limited.

Pdf Link:
Bafna Pharmaceuticals Ltd. – Corporate Insolvency Resolution Process (CIRP)-Updates – Corporate Insolvency Resolution Process (CIRP)

Source : BSE – www.bseindia.com

Read the full article at: https://www.thehindubusinessline.com/companies/announcements/others/bafna-pharmaceuticals-ltd-corporate-insolvency-resolution-process-cirp-updates-corporate-insolvency-resolution-process-cirp/article28295045.ece

Category: LiquidationBy Insolvency Advisory Accountants July 5, 2019

Bafna Pharmaceuticals Ltd. – Corporate Insolvency Resolution Process (CIRP)-Updates – Corporate Insolvency Resolution Process (CIRP) – The Hindu BusinessLine

Sub: Implementation of the Resolution Plan / Capital Reduction

This is in continuation of our earlier intimation dated 05th February 2019 regarding resolution plan which was approved by NCLT, Chennai vide its order dated 01st February 2019 under the Provisions of IBC, 2016.

Pursuant to the Resolution Plan a capital reduction is proposed and the capital of the fully paid up equity shareholders shall be reduced to 10% and consequently the existing 2.36 Crores number of shares shall be reduced to 0.236 Crores.

The Stock exchanges will be intimated in due course for effecting capital reduction.

This is for your information and record.

Pdf Link:
Bafna Pharmaceuticals Ltd. – Corporate Insolvency Resolution Process (CIRP)-Updates – Corporate Ins…

Category: LiquidationBy Insolvency Advisory Accountants February 14, 2019

Bafna Pharmaceuticals Ltd. – Corporate Insolvency Resolution Process (CIRP)-Updates – Corporate Insolvency Resolution Process (CIRP) – The Hindu BusinessLine

Sub: Supervision of the Resolution Plan

Pursuant to the Resolution Plan a Monitoring Committee has been formed with the following members / representatives:
Mr. Radhakrishnan Dharmarajan
Mr. Spurgen David – Representative from SBI
Mr. Nagabhusanam – Representative from IDBI
Mr. M. Sridhar and Ms. S. Hemalatha – Representatives from Corporate Debtor

Pdf Link:
Bafna Pharmaceuticals Ltd. – Corporate Insolvency Resolution Process (CIRP)-Updates – Corporate Insolvency Resolution Process (CIRP)

Source : BSE – www.bseindia.com

Category: LiquidationBy Insolvency Advisory Accountants February 14, 2019

Call Now Button

Bafna Pharmaceuticals Ltd. – Corporate Insolvency Resolution Process (CIRP)-Updates – Corporate Insolvency Resolution Process (CIRP) – The Hindu BusinessLine

Related Posts

Bafna Pharmaceuticals Ltd. – Corporate Insolvency Resolution Process (CIRP)-Updates – Corporate Insolvency Resolution Process (CIRP) – The Hindu BusinessLine

Related Posts

Bafna Pharmaceuticals Ltd. – Corporate Insolvency Resolution Process (CIRP)-Updates – Corporate Insolvency Resolution Process (CIRP) – The Hindu BusinessLine

Related Posts